(Source: IFEBP, July 2026) Coverage Varies Sharply by Employer Size 44% of employers with 500 or more employees covered weight loss drugs but that rose to 64% among employers with 20,000 or more employees
Awareness was also much higher among people who had tried to lose weight or were actively trying to lose weight (18.96%) compared to people with no interest in changing their weight ( 8.55% )
Unmasking fracture risk in type 2 diabetes: the association of longitudinal glycemic hemoglobin level and medications
Meanwhile, biotech firms keep working on new versions of these drugs, possibly even better ones, increasing competition
And while its important not to get ahead of ourselves, its also hard not to feel a little bit excited about what this could mean
However, coverage is not guaranteed